REYON Pharmaceutical Co., Ltd. 102460.KS Stock
REYON Pharmaceutical Co., Ltd. Price Chart
REYON Pharmaceutical Co., Ltd. 102460.KS Financial and Trading Overview
| REYON Pharmaceutical Co., Ltd. stock price | 13680 KRW |
| Previous Close | 17740 KRW |
| Open | 17800 KRW |
| Bid | 17870 KRW x 0 |
| Ask | 17880 KRW x 0 |
| Day's Range | 17730 - 18570 KRW |
| 52 Week Range | 17250 - 29900 KRW |
| Volume | 96.7K KRW |
| Avg. Volume | 50.43K KRW |
| Market Cap | 317.42B KRW |
| Beta (5Y Monthly) | 1.258174 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | 150 (0.83%) |
| Ex-Dividend Date | December 28, 2022 |
| 1y Target Est | N/A |
102460.KS Valuation Measures
| Enterprise Value | 502.8B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.0624197 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 3.267 |
| Enterprise Value/EBITDA | 57.555 |
Trading Information
REYON Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 1.258174 |
| 52-Week Change | -20.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 29900 KRW |
| 52 Week Low | 17250 KRW |
| 50-Day Moving Average | 18494 KRW |
| 200-Day Moving Average | 19606.9 KRW |
102460.KS Share Statistics
| Avg. Volume (3 month) | 50.43K KRW |
| Avg. Daily Volume (10-Days) | 28.54K KRW |
| Shares Outstanding | 17.75M |
| Float | 6.35M |
| Short Ratio | N/A |
| % Held by Insiders | 66.22% |
| % Held by Institutions | 0.58% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | 169.00% |
| Payout Ratio | 0.3513 |
| Last Split Factor | 1.02:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 4.90% |
| Operating Margin (ttm) | 2.64% |
| Gross Margin | 52.85% |
| EBITDA Margin | 5.67% |
Management Effectiveness
| Return on Assets (ttm) | 0.53% |
| Return on Equity (ttm) | 3.08% |
Income Statement
| Revenue (ttm) | 153.91B KRW |
| Revenue Per Share (ttm) | 8795.94 KRW |
| Quarterly Revenue Growth (yoy) | -0.40% |
| Gross Profit (ttm) | N/A |
| EBITDA | 8.74B KRW |
| Net Income Avi to Common (ttm) | 7.47B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 6.00% |
Balance Sheet
| Total Cash (mrq) | 29.41B KRW |
| Total Cash Per Share (mrq) | 1640.75 KRW |
| Total Debt (mrq) | 210.24B KRW |
| Total Debt/Equity (mrq) | 85.11 KRW |
| Current Ratio (mrq) | 2.191 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 9.96B KRW |
| Levered Free Cash Flow (ttm) | -38338301952 KRW |
Profile of REYON Pharmaceutical Co., Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 416 Yeongdong-daero |
| ZIP | N/A |
| Phone | 82 2 793 5557 |
| Website | https://reyonpharm.co.kr |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.
Q&A For REYON Pharmaceutical Co., Ltd. Stock
What is a current 102460.KS stock price?
REYON Pharmaceutical Co., Ltd. 102460.KS stock price today per share is 13680 KRW.
How to purchase REYON Pharmaceutical Co., Ltd. stock?
You can buy 102460.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for REYON Pharmaceutical Co., Ltd.?
The stock symbol or ticker of REYON Pharmaceutical Co., Ltd. is 102460.KS.
Which industry does the REYON Pharmaceutical Co., Ltd. company belong to?
The REYON Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does REYON Pharmaceutical Co., Ltd. have in circulation?
The max supply of REYON Pharmaceutical Co., Ltd. shares is 18.34M.
What is REYON Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
REYON Pharmaceutical Co., Ltd. PE Ratio is now.
What was REYON Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
REYON Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the REYON Pharmaceutical Co., Ltd. company belong to?
The REYON Pharmaceutical Co., Ltd. sector is Healthcare.